These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 9163711)

  • 21. Challenges posed by changes in measles transmission patterns.
    Marufu T; Siziya S; Tshimanga M; Xaba E; Ruwodo C; Silape Z; Baye T; Hhlazo M
    Cent Afr J Med; 1998 Jan; 44(1):5-8. PubMed ID: 9631106
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Monitoring measles eradication in the region of the Americas: critical activities and tools.
    Izurieta H; Venczel L; Dietz V; Tambini G; Barrezueta O; Carrasco P; Quiroga R; André J; Castillo-Solórzano C; Brana M; Laender F; de Quadros CA
    J Infect Dis; 2003 May; 187 Suppl 1():S133-9. PubMed ID: 12721904
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Progress in measles and rubella elimination in Iran.
    Esteghamati A; Gouya MM; Zahraei SM; Dadras MN; Rashidi A; Mahoney F
    Pediatr Infect Dis J; 2007 Dec; 26(12):1137-41. PubMed ID: 18043452
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A measles epidemic controlled by immunisation.
    Mansoor O; Blakely T; Baker M; Tobias M; Bloomfield A
    N Z Med J; 1998 Dec; 111(1079):467-71. PubMed ID: 9972200
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of Lot Quality Assurance Sampling (LQAS) to estimate vaccination coverage helps guide future vaccination efforts.
    Alberti KP; Guthmann JP; Fermon F; Nargaye KD; Grais RF
    Trans R Soc Trop Med Hyg; 2008 Mar; 102(3):251-4. PubMed ID: 18178230
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of urban measles mass campaigns for children aged 9-59 months in Mali.
    Kertesz DA; Touré K; Berthé A; Konaté Y; Bougoudogo F
    J Infect Dis; 2003 May; 187 Suppl 1():S69-73. PubMed ID: 12721894
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Progress toward interruption of endemic measles transmission in Tunisia.
    Garbouj M; Slim A; Ghorbal MB; Khamassi S; Gaafar T; Moshni E; Lievano F
    J Infect Dis; 2003 May; 187 Suppl 1():S172-6. PubMed ID: 12721910
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of mass measles campaigns among children less than 5 years old in Uganda.
    Nanyunja M; Lewis RF; Makumbi I; Seruyange R; Kabwongera E; Mugyenyi P; Talisuna A
    J Infect Dis; 2003 May; 187 Suppl 1():S63-8. PubMed ID: 12721893
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of the measles-rubella mass vaccination campaign in the population covered by Tehran University of Medical Sciences.
    Majdzadeh R; Moradi A; Zeraati H; Sepanlou SG; Zamani G; Zonobi V
    East Mediterr Health J; 2008; 14(4):810-7. PubMed ID: 19166164
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Measles outbreak in the Republic of the Marshall Islands, 2003.
    Hyde TB; Dayan GH; Langidrik JR; Nandy R; Edwards R; Briand K; Konelios M; Marin M; Nguyen HQ; Khalifah AP; O'leary MJ; Williams NJ; Bellini WJ; Bi D; Brown CJ; Seward JF; Papania MJ
    Int J Epidemiol; 2006 Apr; 35(2):299-306. PubMed ID: 16299123
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of a measles vaccine efficacy during a measles outbreak in Mbare, City of Harare Zimbabwe.
    Mahomva AI; Moyo IM; Mbengeranwa LO
    Cent Afr J Med; 1997 Sep; 43(9):254-6. PubMed ID: 9509644
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Progress toward measles elimination in Romania after a mass vaccination campaign and implementation of enhanced measles surveillance.
    Pistol A; Hennessey K; Pitigoi D; Ion-Nedelcu N; Lupulescu E; Walls L; Bellini W; Strebel P
    J Infect Dis; 2003 May; 187 Suppl 1():S217-22. PubMed ID: 12721916
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Emergency measles control activities--Darfur, Sudan, 2004.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2004 Oct; 53(38):897-9. PubMed ID: 15457146
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The theory of measles elimination: implications for the design of elimination strategies.
    Gay NJ
    J Infect Dis; 2004 May; 189 Suppl 1():S27-35. PubMed ID: 15106086
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Measles in rural West Bengal, India, 2005-6: low recourse to the public sector limits the use of vitamin A and the sensitivity of surveillance.
    Murhekar MV; Roy D; Das PK; Bose AS; Ramakrishnan R; Biswas AK; Hutin YJ
    J Infect Dis; 2011 Jul; 204 Suppl 1():S427-32. PubMed ID: 21666195
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Measles epidemic attributed to inadequate vaccination coverage--Campania, Italy, 2002.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2003 Oct; 52(43):1044-7. PubMed ID: 14586297
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Migration as a risk factor for measles after a mass vaccination campaign, Burkina Faso, 2002.
    Yaméogo KR; Perry RT; Yaméogo A; Kambiré C; Kondé MK; Nshimirimana D; Kezaala R; Hersh BS; Cairns KL; Strebel P
    Int J Epidemiol; 2005 Jun; 34(3):556-64. PubMed ID: 15659463
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pattern of susceptibility to measles in Italy. Serological Study Group.
    Salmaso S; Gabutti G; Rota MC; Giordano C; Penna C; Mandolini D; Crovari P
    Bull World Health Organ; 2000; 78(8):950-5. PubMed ID: 10994277
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Progress toward measles elimination--European Region, 2005--2008.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Feb; 58(6):142-5. PubMed ID: 19229166
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of alternative approaches to accelerated measles control: experience in the African region, 1996-2002.
    Otten MW; Okwo-Bele JM; Kezaala R; Biellik R; Eggers R; Nshimirimana D
    J Infect Dis; 2003 May; 187 Suppl 1():S36-43. PubMed ID: 12721884
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.